Infection with SARS-CoV-2 can lead to Coronavirus disease-2019 (COVID-19) and result in
severe acute respiratory distress syndrome (ARDS). Recent reports indicate an increased …

The recent global pandemic of COVID-19 has predisposed a relatively high number of
patients to acute respiratory distress syndrome (ARDS), which carries a risk of developing …

Patients suffering from coronavirus disease-2019 (COVID-19) are susceptible to deadly
secondary fungal infections such as COVID-19-associated pulmonary aspergillosis and …

Patients with severe COVID-19, such as individuals in intensive care units (ICU), are
exceptionally susceptible to bacterial and fungal infections. The most prevalent fungal …

Severe cases of coronavirus disease 2019 (COVID-19) managed in the intensive care unit
are prone to complications, including secondary infections with opportunistic fungal …

Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is threatening public health. A large number of …

Background Critically ill COVID-19 patients are highly susceptible to opportunistic fungal
infection due to many factors, including virus-induced immune dysregulation, host-related …

Background Invasive fungal infections (IFI) are increasing in prevalence in recent years. In
the last few months, the rise of COVID-19 patients has generated a new escalation in …

Background The COVID-19 pandemic has resulted in unprecedented healthcare
challenges, and COVID-19 has been linked to secondary infections. Candidemia, a fungal …

There is scarce information on the actual incidence of candidemia in COVID-19 patients. In
addition, comparative studies of candidemia episodes in COVID-19 and non-COVID-19 …